摘要: |
目的:将盐酸尼卡地平制成肠溶缓释固体分散体,以促进其在肠道内溶出,提高制剂的生物利用度。方法:以水溶性材料(PEG6000)和肠溶性材料(Ⅱ丙烯酸树脂)为混合载体,采用溶剂法制备了盐酸尼卡地平固体分散体。通过正交实验设计,筛选得到了具有理想肠溶缓释效果的处方。结果:盐酸尼卡地平制成的肠溶缓释固体分散体在人工肠液中3 h释放量为54.33%,10 h释放量为80.18%。其体外释药方式符合Higuchi 方程。DTA分析和X-射线粉末衍射证实药物以无定形态分散于载体中。结论:以固体分散体制备的肠溶缓释微丸具有促进药物溶出、定位缓慢释放的作用。 |
关键词: 盐酸尼卡地平 固体分散体 迟效制剂 |
DOI: |
|
基金项目: |
|
Study on nicardipine hydrochloride intestinal-dissolved sustained-release pellets |
崔孟,孙其荣,钟延强,刘善奎 |
() |
Abstract: |
Objective: To prepare nicardipine hydrochloride solid dispersion to promote the dissolution and improve bioavailability of drugs in vivo and in vitro. Methods: Nicardipine hydrochloride solid dispersion was developed using Ⅱ acrylic resin and PEG6000 as mixed carrier by the solvent evaporating method. The orthogonal test was employed in the design of the formulations. Results: The percentage released of nicardipine hydrochloride solid dispersion in artificial intestinal liquid was 54.33%and 80.18%at 3 h and 10 h, respectively. The DTA and X-ray powder diffractometry showed that nicardipine hydrochloride was amorphously dispersed in the solid dispersion. The released profiles in vitro of the solid dispersion followed Higuchi equation. Conclusion: Nicardipine hydrochloride intestinal-dissolved sustained-release pellets are prepared by traditional method which combine the advantages of pellets and solid dispersion. |
Key words: nicardipine hydrochloride solid dispersion sustained-release pellets |